chr9:130911350:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr9:130,911,350-130,915,732 |
| hg38 | chr9:128,149,071-128,153,453 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| <0.001 | choriocarcinoma | NA | BeFree | Detail | |
| <0.001 | colitis | NA | BeFree | Detail | |
| <0.001 | ulcerative colitis | NA | BeFree | Detail | |
| 0.083 | Colonic Neoplasms | NA | LHGDN,RGD | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | Cyst | NA | BeFree | Detail | |
| 0.120 | contact dermatitis | NA | CTD_human | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| <0.001 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
| 0.080 | Diabetic Nephropathy | NA | BeFree,RGD | Detail | |
| <0.001 | diverticulitis | NA | BeFree | Detail | |
| <0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
| <0.001 | Fatty Liver | NA | BeFree | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| 0.003 | IgA glomerulonephritis | NA | LHGDN | Detail | |
| <0.001 | Heart failure | NA | BeFree | Detail | |
| <0.001 | congestive heart failure | NA | BeFree | Detail | |
| 0.120 | heart valve disease | NA | CTD_human | Detail | |
| 0.120 | Hepatitis, Animal | NA | CTD_human | Detail | |
| 0.001 | HIV Infections | NA | BeFree | Detail | |
| <0.001 | Hypertensive disease | NA | BeFree | Detail | |
| <0.001 | pulmonary hypertension | Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery... | BeFree | 25076856 | Detail |
| 0.123 | Inflammation | NA | CTD_human,LHGDN | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| 0.127 | Kidney Diseases | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.003 | Kidney Failure, Acute | Our findings suggest that neutrophils are the major source of circulating LCN2 i... | BeFree | 24599361 | Detail |
| 0.003 | Kidney Failure, Acute | As neutrophil gelatinase-associated lipocalin (NGAL) has been shown to predict a... | BeFree | 25611655 | Detail |
| <0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
| 0.003 | Polycystic Kidney Diseases | NA | BeFree,LHGDN | Detail | |
| 0.003 | leukemia | NA | BeFree,LHGDN | Detail | |
| 0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,LHGDN | Detail | |
| 0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
| <0.001 | lichen planus | NA | BeFree | Detail | |
| <0.001 | liver cirrhosis | NA | BeFree | Detail | |
| 0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| <0.001 | Lung diseases | NA | BeFree | Detail | |
| 0.003 | Lupus Erythematosus, Systemic | NA | LHGDN | Detail | |
| <0.001 | multiple sclerosis | NA | BeFree | Detail | |
| 0.003 | myocardial infarction | NA | BeFree,LHGDN | Detail | |
| 0.080 | myocarditis | NA | BeFree,RGD | Detail | |
| 0.003 | Nasal Polyps | NA | BeFree,LHGDN | Detail | |
| 0.127 | Neoplasm Metastasis | Because breast cancer patient survival inversely correlates with metastasis, we ... | BeFree,CTD_human,LHGDN | 24467226 | Detail |
| 0.127 | Neoplasm Metastasis | Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9... | BeFree,CTD_human,LHGDN | 25542236 | Detail |
| 0.127 | Neoplasm Metastasis | Therefore, targeted inhibition of LCN2 may represent a therapeutic strategy to p... | BeFree,CTD_human,LHGDN | 25728945 | Detail |
| <0.001 | nervous system disorder | NA | BeFree | Detail | |
| 0.083 | obesity | Plasma NGAL may play a role in the development of insulin resistance in GDM, and... | BeFree,RGD | 24530115 | Detail |
| 0.083 | obesity | Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links... | BeFree,RGD | 25468909 | Detail |
| <0.001 | Obesity, Morbid | NA | BeFree | Detail | |
| 0.003 | Degenerative polyarthritis | NA | LHGDN | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| <0.001 | Ovarian Diseases | NA | BeFree | Detail | |
| 0.005 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
| <0.001 | pancreatitis | NA | BeFree | Detail | |
| <0.001 | Parakeratosis | NA | BeFree | Detail | |
| <0.001 | peritonitis | NA | BeFree | Detail | |
| <0.001 | Pneumococcal Infections | NA | BeFree | Detail | |
| <0.001 | pneumonia | NA | BeFree | Detail | |
| <0.001 | Lobar Pneumonia | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| <0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
| <0.001 | polyps | NA | BeFree | Detail | |
| <0.001 | Precancerous Conditions | NA | BeFree | Detail | |
| <0.001 | Prostatic Neoplasms | NA | BeFree | Detail | |
| <0.001 | psoriasis | NA | BeFree | Detail | |
| 0.001 | kidney failure | NA | BeFree | Detail | |
| 0.003 | Reperfusion Injury | NA | LHGDN | Detail | |
| <0.001 | Respiratory Tract Infections | NA | BeFree | Detail | |
| <0.001 | Septicemia | At the time of first sample collection in the ED, gene expression of Interleukin... | BeFree | 25343379 | Detail |
| 0.003 | sialadenitis | NA | BeFree,LHGDN | Detail | |
| <0.001 | Dermatologic disorders | NA | BeFree | Detail | |
| <0.001 | Skin Neoplasms | NA | BeFree | Detail | |
| <0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
| <0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
| <0.001 | ureteral obstruction | NA | BeFree | Detail | |
| <0.001 | urinary tract infection | Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is... | BeFree | 25398327 | Detail |
| <0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
| <0.001 | gestational diabetes | The changes of neutrophil gelatinase-associated lipocalin in plasma and its expr... | BeFree | 24530115 | Detail |
| <0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
| <0.001 | Polycystic Kidney, Autosomal Dominant | NA | BeFree | Detail | |
| <0.001 | Acute appendicitis NOS (disorder) | NA | BeFree | Detail | |
| <0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9... | BeFree | 25542236 | Detail |
| <0.001 | esophageal carcinoma | NA | BeFree | Detail | |
| <0.001 | congenital heart disease | In this study, we observed that the expression levels of Lcn2 were significantly... | BeFree | 25076856 | Detail |
| <0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
| 0.001 | Secondary malignant neoplasm of lung | Overexpression of LCN2 in ESCC cells accelerated cell migration and invasion in ... | BeFree | 26190820 | Detail |
| <0.001 | acute myocardial infarction | NA | BeFree | Detail | |
| <0.001 | Streptococcal pneumonia | NA | BeFree | Detail | |
| <0.001 | Aortic Aneurysm, Abdominal | NA | BeFree | Detail | |
| 0.002 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
| <0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
| <0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
| <0.001 | Memory impairment | NA | BeFree | Detail | |
| 0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Fibrosis, Liver | We identified a PPI network module associated with liver fibrosis that includes ... | BeFree | 25380136 | Detail |
| <0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
| 0.003 | Azotemia | NA | BeFree,LHGDN | Detail | |
| <0.001 | Sepsis | At the time of first sample collection in the ED, gene expression of Interleukin... | BeFree | 25343379 | Detail |
| <0.001 | Infectious colitis | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of esophagus | Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipo... | BeFree | 25109818 | Detail |
| <0.001 | Squamous cell carcinoma of esophagus | Shortest path analyses in the protein-protein interaction network of NGAL (neutr... | BeFree | 25169543 | Detail |
| <0.001 | Squamous cell carcinoma of esophagus | Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carc... | BeFree | 26190820 | Detail |
| 0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Optic Atrophy, Autosomal Dominant | NA | BeFree | Detail | |
| <0.001 | Impaired cognition | NA | BeFree | Detail | |
| <0.001 | intrahepatic cholangiocarcinoma | The downregulation of LCN2 expression was blunted when vitamin D receptor (VDR) ... | BeFree | 24939880 | Detail |
| 0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Cervical intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
| <0.001 | Cervical intraepithelial neoplasia grade 2 | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of prostate | Over-expression of lipocalin 2 promotes cell migration and invasion through acti... | BeFree | 25728945 | Detail |
| <0.001 | Hematologic Neoplasms | By sandwich ELISA, serum and urinary LCN2 levels were measured in 36 patients wi... | BeFree | 24599361 | Detail |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| 0.121 | Chronic Kidney Insufficiency | The inflammation-lipocalin 2 axis may contribute to the development of chronic k... | BeFree,CTD_human | 24235082 | Detail |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of liver | Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon can... | BeFree | 25740061 | Detail |
| <0.001 | Overweight | Plasma NGAL may play a role in the development of insulin resistance in GDM, and... | BeFree | 24530115 | Detail |
| <0.001 | Recurrent tumor | NA | BeFree | Detail | |
| <0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Prerenal uremia syndrome | NA | BeFree | Detail | |
| 0.004 | Carcinogenesis | It was recently reported that lipocalin 2 (Lcn2) is up-regulated in a wide array... | BeFree | 25076856 | Detail |
| 0.002 | prostate carcinoma | Over-expression of lipocalin 2 promotes cell migration and invasion through acti... | BeFree | 25728945 | Detail |
| 0.001 | Myeloid Leukemia, Chronic | LCN-2 mRNA showed a near 50-fold increase in expression, accompanied by down-reg... | BeFree | 21950422 | Detail |
| <0.001 | invasive cancer | NA | BeFree | Detail | |
| <0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
| 0.004 | breast carcinoma | This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing-... | BeFree | 24467226 | Detail |
| 0.004 | breast carcinoma | Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links... | BeFree | 25468909 | Detail |
| <0.001 | polycythemia vera | LCN-2 mRNA showed a near 50-fold increase in expression, accompanied by down-reg... | BeFree | 21950422 | Detail |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon can... | BeFree | 25740061 | Detail |
| <0.001 | Carcinoma of bladder | Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hyp... | BeFree | 24570342 | Detail |
| <0.001 | cervical cancer metastasis | NA | BeFree | Detail | |
| <0.001 | Central nervous system lesion | NA | BeFree | Detail | |
| <0.001 | Unverricht-Lundborg syndrome | The degree of temporal changes of P25 and N35 in ULD was similar or even lower t... | BeFree | 25023721 | Detail |
| <0.001 | Endothelial dysfunction | NA | BeFree | Detail | |
| <0.001 | Post MI | NA | BeFree | Detail | |
| 0.120 | Drug-Induced Liver Injury | NA | CTD_human | Detail | |
| <0.001 | Carcinoma, Pancreatic Ductal | NA | BeFree | Detail | |
| <0.001 | Renal ischaemia | NA | BeFree | Detail | |
| <0.001 | Vascular inflammations | NA | BeFree | Detail | |
| <0.001 | Tauopathies | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| <0.001 | Mild cognitive disorder | NA | BeFree | Detail | |
| <0.001 | Pancreatic intraepithelial neoplasia | NA | BeFree | Detail | |
| <0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
| <0.001 | mesenchymal cell neoplasm | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.008 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | Hippocampal sclerosis | NA | BeFree | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| <0.001 | colorectal cancer | NA | BeFree | Detail | |
| 0.001 | Chronic Kidney Diseases | The inflammation-lipocalin 2 axis may contribute to the development of chronic k... | BeFree | 24235082 | Detail |
| 0.001 | Chronic Kidney Diseases | While urinary NGAL was greater in CKD than control subjects, exosomal NGAL mRNA ... | BeFree | 24918752 | Detail |
| 0.001 | Chronic Kidney Diseases | Albumin-creatinine ratio (ACR), 4 tubular injury biomarkers (interleukin 18 [IL-... | BeFree | 25921719 | Detail |
| <0.001 | Cold Ischemia | NA | BeFree | Detail | |
| 0.003 | Delayed Graft Function | NA | LHGDN | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | Severe Sepsis | Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis... | BeFree | 25343379 | Detail |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.002 | liver carcinoma | NA | BeFree | Detail | |
| <0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| 0.200 | Acute kidney injury | NA | CTD_human,RGD | Detail | |
| <0.001 | Progressive cGVHD | NA | BeFree | Detail | |
| <0.001 | Triple Negative Breast Neoplasms | NA | BeFree | Detail | |
| <0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Anemia in malignant neoplastic disease | NA | BeFree | Detail | |
| <0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
| 0.002 | Spontaneous abortion | NA | GAD | Detail | |
| 0.004 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | adenoma | NA | BeFree | Detail | |
| <0.001 | Alzheimer's disease | NA | BeFree | Detail | |
| <0.001 | amyotrophic lateral sclerosis | NA | BeFree | Detail | |
| <0.001 | anemia | NA | BeFree | Detail | |
| <0.001 | Cooley's anemia | NA | BeFree | Detail | |
| <0.001 | Aneurysm | NA | BeFree | Detail | |
| <0.001 | appendicitis | NA | BeFree | Detail | |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| 0.120 | rheumatoid arthritis | NA | CTD_human | Detail | |
| <0.001 | atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Bacterial Infections | In patients without AKI and bacterial infection, at 1 week after SCT, the median... | BeFree | 24599361 | Detail |
| <0.001 | Pneumonia, Bacterial | NA | BeFree | Detail | |
| <0.001 | bacteriuria | In a human cohort of women with recurrent E. coli UTIs, urine LCN2 levels were a... | BeFree | 25398327 | Detail |
| 0.123 | beta thalassemia | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hyp... | BeFree | 24570342 | Detail |
| 0.004 | Malignant neoplasm of breast | This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing-... | BeFree | 24467226 | Detail |
| 0.004 | Malignant neoplasm of breast | Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links... | BeFree | 25468909 | Detail |
| <0.001 | Breast Diseases | NA | BeFree | Detail | |
| 0.120 | calcinosis | NA | CTD_human | Detail | |
| <0.001 | Malignant tumor of colon | Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon can... | BeFree | 25740061 | Detail |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our findings suggest that neutrophils are the major source of circulating LCN2 in normal and infecte... | DisGeNET | Detail |
| As neutrophil gelatinase-associated lipocalin (NGAL) has been shown to predict acute renal failure, ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Because breast cancer patient survival inversely correlates with metastasis, we engineered vehicles ... | DisGeNET | Detail |
| Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) are protein... | DisGeNET | Detail |
| Therefore, targeted inhibition of LCN2 may represent a therapeutic strategy to prevent the metastasi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Plasma NGAL may play a role in the development of insulin resistance in GDM, and the high levels of ... | DisGeNET | Detail |
| Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrop... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women w... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The changes of neutrophil gelatinase-associated lipocalin in plasma and its expression in adipose ti... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we observed that the expression levels of Lcn2 were significantly elevated in a rat P... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Overexpression of LCN2 in ESCC cells accelerated cell migration and invasion in vitro, and promoted ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We identified a PPI network module associated with liver fibrosis that includes known liver fibrosis... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrop... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression... | DisGeNET | Detail |
| Shortest path analyses in the protein-protein interaction network of NGAL (neutrophil gelatinase-ass... | DisGeNET | Detail |
| Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The downregulation of LCN2 expression was blunted when vitamin D receptor (VDR) was knocked down, im... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling... | DisGeNET | Detail |
| By sandwich ELISA, serum and urinary LCN2 levels were measured in 36 patients with hematologic malig... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhi... | DisGeNET | Detail |
| Plasma NGAL may play a role in the development of insulin resistance in GDM, and the high levels of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| It was recently reported that lipocalin 2 (Lcn2) is up-regulated in a wide array of malignant condit... | DisGeNET | Detail |
| Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling... | DisGeNET | Detail |
| LCN-2 mRNA showed a near 50-fold increase in expression, accompanied by down-regulation of SLC22A17,... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing--significantly reduc... | DisGeNET | Detail |
| Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast... | DisGeNET | Detail |
| LCN-2 mRNA showed a near 50-fold increase in expression, accompanied by down-regulation of SLC22A17,... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhi... | DisGeNET | Detail |
| Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inor... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The degree of temporal changes of P25 and N35 in ULD was similar or even lower than that of healthy ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease. | DisGeNET | Detail |
| While urinary NGAL was greater in CKD than control subjects, exosomal NGAL mRNA was unchanged. | DisGeNET | Detail |
| Albumin-creatinine ratio (ACR), 4 tubular injury biomarkers (interleukin 18 [IL-18], kidney injury m... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In patients without AKI and bacterial infection, at 1 week after SCT, the median blood neutrophil co... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In a human cohort of women with recurrent E. coli UTIs, urine LCN2 levels were associated with UTI e... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inor... | DisGeNET | Detail |
| This synergistic approach--coupling the CXCR4 axis blockade with Lcn2 silencing--significantly reduc... | DisGeNET | Detail |
| Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg19
- Position
- chr9:130,911,350-130,915,732
- Variant Type
- snv
Genome browser